CIK 0001285819
- Non-accelerated filer
- Smaller reporting company
OMEROS CORP
Sign in to watch- Ticker
- OMER
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- WA
- Entity type
- Operating
- EIN
- 911663741
- Phone
- +1 206-676-5000
- Business address
- 201 ELLIOTT AVENUE WEST, SEATTLE, WA, 98119
- 4 Derivatives Options or other derivatives
- 4 Open-market sale VP Finance and CAO sold 23,792 shares at an average $23.80 ($566,160)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market sale VP Patent and General Counsel sold 62,528 shares at $21.45 ($1,341,226)
- 4 Open-market sale VP Finance and CAO sold 1,020 shares at $22.45 ($22,899)
- 4 Exercise or conversion Chairman, CEO & President acquired 142,001 shares (option exercise)
- 4 Exercise or conversion VP Patent and General Counsel acquired 8,000 shares (option exercise)
- 4 Open-market sale VP Finance and CAO sold 12,000 shares at $24.95 ($299,400)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market sale VP Finance and CAO sold 24,000 shares at an average $21.20 ($508,800)
- 4 Open-market sale Director sold 3,000 shares at $16.49 ($49,474)
- 4 Exercise or conversion VP Patent and General Counsel acquired 2,040 shares (option exercise)
- 4 Derivatives Options or other derivatives
Page 8 of 15 · 295 filings